AASLD looks forward to having you join us and participate in the single most influential and wide-ranging dialogue about liver disease in the world. Following are guidelines to help you prepare for your session.
All oral abstract presenters of The Liver Meeting® are required to:
* You must register for the Annual Meeting by October 12 to receive advance registration rates. Access into The Liver Meeting® sessions, poster or exhibit halls will not be permitted without an attendee badge. International attendees may obtain a Letter of Invitation for visa purposes.
Review the Presentation Information tab to assist you in preparing for your session.
Q: Where is the link to submit an abstract?
A: From the AASLD homepage hover over the “Events and Professional Development” header, select The Liver Meeting®. From this page, click on “Abstracts” on the left-hand menu. Direct URL is https://aasld.confex.com/aasld/2018/abstracts/papers/index.cgi.
Q: When will the abstract submission site close?
A: The submission site closed on June 1, 2018 11:59 pm ET (US).
Q: When will I be notified whether my work has been accepted for presentation at The Liver Meeting®?
A: Notifications will be sent electronically to presenting authors and co-authors in August. Late-breaking abstract notifications will be sent out in early October.
Q: Can I submit my abstract past June 1st?
A: Unfortunately, AASLD does not allow late submissions.
Q: What is the abstract fee?
A: There is a $65 non-refundable fee to submit an abstract. Only online credit card payments (done through the submission site) are permitted. We do not allow money transfers or check payment.
Q: Where can I find submission guidelines and categories?
A: From the AASLD homepage hover over the “Events and Professional Development” navigation, select The Liver Meeting®, then Abstracts.
Q: Who can I talk to about technical issues (i.e. Login information, abstract formatting – tables, graphs, images)?
A: Contact our vendor, The Conference Exchange, via phone at +1 401-334-0220 between the hours of 8:30 am and 6:00 pm ET Monday through Friday.
Q: When are disclosures due?
A: ALL Disclosures are collected at the time of abstract acceptance. Submitting authors will NOT be allowed to submit disclosures on a co-author's behalf. Co-authors will need to sign into the abstract site separately to complete their disclosures (an auto-generated email with instructions will be sent to the email address(s) indicated by the submitting author at the time of abstract acceptance).
Q: One of my Co-Authors did not receive their email to complete their disclosure. How do they complete it?
A: Have your Co-Author check their SPAM folder. The email would have come from email@example.com. If you still cannot locate the message, contact firstname.lastname@example.org for assistance.
Q: How many authors can be on my abstract?
A: There is no maximum.
Q: Are my abstract title and authors tallied in the 2,500-character count?
A: No they are not. The title should be kept brief, but long enough to clearly identify the nature of the study.
Q: Are my abstract images and/or tables included in the 2,500-character count?
A: No they are not. Images are in addition to the 2,500-character count. There is a maximum of one table or graphic, limited to 2" height by 3" width.
Q: Where can I apply for abstract awards? What is the deadline?
A: The deadline to apply for an abstract award was June 1 at 11:59 pm ET.
Q: What can I do if my research is not completed until after the June 1 deadline?
A: You can submit your work as a late-breaking abstract submission. Visit the abstracts web page for further details as there are extra requirements for late-breaking submissions. The late-breaking abstract submission period will be from September 10 – September 17. The cost to submit an abstract is $300.
Q: Are we allowed to update author information and make changes to the submitted abstract after the deadline?
A: The only updates allowed after the June 1 deadline are adjustments to an existing author’s name and email address NO LATER THAN AUGUST 10. All author change requests must be sent in writing to email@example.com. Absolutely no changes to abstract content will be accepted after June 1.
Q: What if scheduling conflict arises after the author change deadline and the presenting author can no longer attend The Liver Meeting®?
A: Co-authors can present in place of the presenting authors. However, the original presenting author’s name will remain listed on The Liver Meeting® app and in the Program Guide.
Q: Is there a deadline for withdrawing abstracts?
A: Yes, the deadline is August 10. Requests to withdraw must be sent in writing to firstname.lastname@example.org. Withdrawals will NOT be accepted past this deadline.
Q: Is there a deadline that I must register for The Liver Meeting® for my work to be considered for presentation?
A: The presenting author must be registered for The Liver Meeting® to gain access to the meeting and present their work. AASLD recommends registering for The Liver Meeting® upon notification that your abstract has been accepted for presentation. Early registration ends October 12.
Q: Can I present my work at The Liver Meeting® if it has already been presented elsewhere?
A: Information presented prior to The Liver Meeting® in the US is not permissible and will not be accepted as part of the meeting. If your work has been presented internationally, you may also present at The Liver Meeting®. Refer to the abstracts page for abstract submission guidance.
Q: Where and when will my work be published if accepted?
A: Accepted abstracts will be published in the October HEPATOLOGY journal supplement, which will be available in print and posted online through Wiley (navigate from the AASLD homepage – Publications tab – HEPATOLOGY – Find Issues – select the Issue you are seeking).
Abstracts will also be available in The Liver Meeting® app (available in October).
Late-Breaking abstracts will be published in the December issue of HEPATOLOGY (print and online), and will be available in the online planner of The Liver Meeting® app in mid-October.
Q: How can I access abstracts submitted as part of a previous Liver Meeting®?
A: You can view past meeting abstracts on the HEPATOLOGY journal site (see above for navigation instructions). If you have an AASLD account, you can also view past meeting abstracts through LiverLearning® and searching “presentation."
2018 abstracts are published in the October 2018 supplement. (Volume 68, Issue S1)
Q: Will there be a printing service onsite for Poster presentations?
A: AASLD works with an outside vendor for poster printing. We will publish a link on our abstracts page that will direct you to poster guidelines, costs, and deadlines once abstracts have been reviewed and scored. Submissions for poster printing must be sent to the vendor before the deadline stated by the vendor to be available for onsite pickup.
All presentations at this year's Meeting will be in WIDESCREEN format. To take full advantage of the new widescreen format, we recommend that you build or convert your presentation to 16:9. For more information on how to change an existing 4:3 presentation into a 16:9 widescreen format, review the information below. For your convenience, the AASLD’s official Meeting PowerPoint template is in widescreen format.
For technical assistance regarding your presentation, email email@example.com.
IMPORTANT: If you convert an existing presentation to widescreen, your slides will expand to the new size. If you have any videos or photos in an existing PowerPoint, they may need to be resized so they do not appear stretched. Also, be sure to check animations to ensure the elements line up correctly.
If your slides contain images, illustrations, figures, tables or text that has been published elsewhere or came from another source, you are responsible for requesting and securing permission from the copyright holder to include the material(s) in your presentation slides and authorize AASLD to record the presentation.
All presenters are responsible for removing all patient-identifying information from their presentation slides. If your slides contain images or information about patients or other individuals, you are responsible for obtaining appropriate patient consent (including HIPAA authorization, if applicable) to include the material in your slides and authorize AASLD to record the presentation. For more information, visit Health Information Privacy.
AASLD is excited to announce that we will be using a new system for our meeting this year – the system is easier to navigate and will now have a “Speaker Center” where you will access important information related to the meeting all year long. Use your AASLD login information to access your Speaker Center.
All faculty members (including Program Planners, Program Chairs, Moderators, Panelists, and Presenters) are expected to fully disclose all financial relationships with a commercial interest. By accepting our invitation, you agreed to comply with AASLD's Disclosure Policy and the ACCME Standards for Commercial Support in the planning, development and presentation of educational activities.
Presentations may be recorded for printed and electronic distribution by AASLD. This includes posting on the eLearning portal LiverLearning®, any AASLD affiliated websites and printed communications. If a course is selected for recording, presenters will have the ability to accept or decline this policy prior to the meeting.
A disclosure slide will automatically be inserted by AASLD as the first slide of your presentation, based on the information provided during the invitation process. You will be required to review and approve the disclosure slide in the Speaker Ready Room. Any presenter changes will also require an update of the disclosure slide, which can be completed before arriving onsite or in the Speaker Ready Room. More information will be provided in August.
Off-Label, Investigational Use
When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is included in the content of an educational activity, you are required to verbally disclose that the product is not labeled for the use under discussion or that the product is still investigational, in accordance with the ACCME standards and the Food and Drug Administration requirements.
Additional information or data not included in your original abstract submission is embargoed until 8:00 am ET Friday, November 9, and may not be released before this date. View the full Embargo Policy.